SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
Saved in:
Main Authors: | Shujing Xu (Author), Xinyong Liu (Author), Peng Zhan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bibliometric analysis and visualization of research trends on HIV-1 capsid inhibitors (2000-2022)
by: Lin Sun, et al.
Published: (2023) -
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India
by: Katherine Floyd, et al.
Published: (2006) -
Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
by: Tao Zhang, et al.
Published: (2022) -
Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
by: Shenghua Gao, et al.
Published: (2023) -
Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
by: Yahong Liu, et al.
Published: (2023)